About Jinlan Pharm-Drugs Technology Co., Ltd. - Agriculture Supplier in China

Jinlan Pharm-Drugs Technology Co., Ltd. is based in China and currently lists five active products in its catalogue. The five items are Anastrozole, Disodium clodronate tetrahydrate, Linezolid, Mycophenolate mofetil and Imatinib mesylate, all classified under the supplier’s top category of Agriculture despite being pharmaceutical active ingredients. The catalogue does not provide HS codes, so each API is recorded under the general pharmaceutical API classification used in international trade. The supplier is identified as an imported tier with a harbor trust tier, indicating it operates through established import channels for buyers outside China.

The listed APIs cover several therapeutic areas: Anastrozole is an aromatase inhibitor used in hormone‑dependent cancers, Disodium clodronate tetrahydrate is a bisphosphonate for bone disorders, Linezolid is an oxazolidinone antibiotic, Mycophenolate mofetil is an immunosuppressant for transplant patients, and Imatinib mesylate is a tyrosine‑kinase inhibitor for chronic myeloid leukemia. Each product is typically supplied as a fine powder or crystalline solid suitable for formulation. The supplier’s portfolio reflects a focus on high‑potency small‑molecule drugs that are commonly sourced by formulators and contract manufacturers.

Product Range and Specialties of Jinlan Pharm-Drugs Technology Co., Ltd.

The product catalogue includes five small‑molecule APIs. In the pharmaceutical market, Anastrozole, Linezolid, Mycophenolate mofetil and Imatinib mesylate are usually offered with a minimum purity of 99.5 % as defined by USP or EP monographs, while Disodium clodronate tetrahydrate is often supplied at 98 % - 99 % purity due to its hydrated salt form. Typical specifications also cover moisture content (≤0.5 % for most APIs), particle size distribution (often 50 - 200 µm), and residual solvent limits in line with ICH Q3C. Buyers frequently encounter these APIs in bulk containers such as 25 kg IBCs or 50 kg drums, and they may be repackaged into 1 kg or 500 g HDPE bottles for downstream processing.

Industry practice for these categories includes providing a Certificate of Analysis (CoA) that lists assay, impurity profile, water content, and heavy‑metal limits. For antibiotics like Linezolid, sterility testing and microbial limit tests are standard, while oncology agents such as Imatinib require additional testing for endotoxins and residual solvents. The catalogue’s focus on these five APIs aligns with common demand from generic drug manufacturers and contract research organizations that require consistent batch‑to‑batch quality and detailed analytical data.

Trade and Export Information - Jinlan Pharm-Drugs Technology Co., Ltd.

China is a major exporter of pharmaceutical APIs, and shipments are generally recorded under HS Chapter 30 (e.g., 3004 for medicaments). Exporters of APIs from China commonly ship to North America, the European Union, and emerging markets in Southeast Asia, where regulatory bodies often require GMP compliance and a full drug master file. Typical logistics involve 20‑foot or 40‑foot containers with temperature‑controlled or ventilated options, depending on the API’s stability. Buyers should expect standard Incoterms such as FOB Shanghai or CIF Hong Kong, with bulk packaging in sealed drums or IBCs to protect product integrity during transit.

Regulatory expectations for Chinese API suppliers include documentation of Good Manufacturing Practice (GMP) certification, ISO 9001 quality‑management systems, and compliance with the importing country’s pharmacopeial standards (USP, EP, JP). Import inspections may be conducted under the World Customs Organization’s Revised Kyoto Convention framework, and many buyers request third‑party audit reports from agencies such as SGS or Bureau Veritas. While the supplier’s specific certifications are not listed in the provided facts, these are the typical credentials that international purchasers verify before finalising a contract.

Sourcing from Jinlan Pharm-Drugs Technology Co., Ltd. - Buyer Guidance

When sourcing from Jinlan Pharm-Drugs Technology Co., Ltd., buyers should request the latest GMP certificate, a full CoA for each API batch, and any available stability data that demonstrates compliance with ICH Q1A(R2). Because the catalogue does not specify batch size, it is advisable to confirm the minimum order quantity (MOQ) for each API, which commonly ranges from 5 kg to 25 kg for bulk chemicals. Verify that the supplier can provide a detailed impurity profile, including any identified genotoxic impurities, as these are critical for regulatory submissions in the EU and US markets.

Buyers are also encouraged to ask for a recent third‑party audit report and to confirm the packaging format (e.g., sealed 25 kg IBCs or 1 kg HDPE bottles) to ensure compatibility with their own logistics chain. Requesting a trial sample of 500 g to 1 kg, accompanied by a provisional CoA, helps assess assay accuracy and impurity limits before committing to a full production batch. Confirming the Incoterm, lead time (typically 30 - 45 days from order confirmation for bulk API production), and any required export documentation such as a Certificate of Origin will streamline customs clearance.

What API products does Jinlan Pharm-Drugs Technology Co., Ltd. list in its catalogue?

The catalogue lists five pharmaceutical APIs: Anastrozole, Disodium clodronate tetrahydrate, Linezolid, Mycophenolate mofetil and Imatinib mesylate.

Are purity specifications provided for these APIs?

Purity specifications are not stated in the facts, but industry standards for these APIs usually require a minimum assay of 99.5 % for most small‑molecule drugs, with Disodium clodronate tetrahydrate often supplied at 98 % - 99 % purity.

Which certifications should a buyer request from this supplier?

Buyers should request the supplier’s current GMP certificate, ISO 9001 quality‑management certification, and a recent third‑party audit report, as these are common requirements for API imports.

What is the typical packaging format for bulk APIs from China?

Bulk APIs are commonly packed in sealed 25 kg intermediate bulk containers (IBCs), 50 kg drums, or repackaged into 1 kg HDPE bottles for downstream use.

Which HS code family applies to these pharmaceutical APIs?

While the supplier’s catalogue does not list HS codes, pharmaceutical APIs are generally classified under HS Chapter 30, specifically heading 3004 for medicaments.

What are common lead times for API orders from Chinese manufacturers?

Lead times usually range from 30 to 45 days after order confirmation, depending on batch size and production scheduling.

What Incoterms are typically used for shipping these APIs?

Exporters from China often use FOB Shanghai or CIF Hong Kong, allowing buyers to choose the level of responsibility for freight and insurance.

How should a buyer verify the quality of a sample before a full order?

A buyer should request a 500 g - 1 kg trial sample accompanied by a provisional Certificate of Analysis that includes assay, impurity profile, moisture content and residual solvent limits.